Status:

COMPLETED

Imiquimod in Children With Plaque Morphea

Lead Sponsor:

The Hospital for Sick Children

Conditions:

Scleroderma, Localized

Eligibility:

All Genders

6-18 years

Phase:

PHASE3

Brief Summary

Morphea is very hard to treat. In a small number of adult patients, Imiquimod has proven to be beneficial in decreasing the thickness of the morphea plaques , while improving their appearance. There a...

Detailed Description

Design: Prospective, open label, pilot study Settings: The Hospital for Sick Children, Specialized Morphea Clinic Study population: * Children 6-18 years of age * Plaque morphea measuring less than...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Age at diagnosis 6 to 18 years of age
  • Morphea plaques
  • Female subjects of childbearing potential must have a negative urine pregnancy test
  • Signed consent/assent form
  • Exclusion criteria:
  • Children who received topical corticosteroids, tacrolimus, vitamin D derivatives (calcipotriol, calcipotriol-betamethasone dipropionate) to the affected area in the previous four weeks
  • Children who were previously treated with Imiquimod on the affected areas
  • Children with no demonstrable ultrasonographic changes at the baseline evaluation
  • Children with evidence of skin breakdown on the proposed area to be treated at the time of enrollment due to potential increased absorption of the medication through impaired skin barrier
  • Female subjects of childbearing potential who do not agree to practice effective birth control methods for the duration of the study
  • Children who are/were (in the past 6 months) treated with systemic medications such as methotrexate and/or systemic corticosteroids
  • Co-morbidities: systemic sclerosis, juvenile rheumatoid arthritis, other systemic diseases

Exclusion

    Key Trial Info

    Start Date :

    September 1 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2009

    Estimated Enrollment :

    10 Patients enrolled

    Trial Details

    Trial ID

    NCT00147771

    Start Date

    September 1 2005

    End Date

    September 1 2009

    Last Update

    August 2 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    The Hospital for Sick Children

    Toronto, Ontario, Canada, M5G 1X8